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Abstract 
Introduction: Death certification is often used to identify patients with certain diseases in 
epidemiologic research.  There have been few studies looking at the accuracy of recording 
of parkinsonian diagnoses, any associated dementia and the cause of death on death 
certificates in people with parkinsonian conditions. This study aimed to assess this. 
Methods: Data for these analyses were derived from a prospective incident cohort of 
degenerative/vascular parkinsonian syndromes with lifelong follow-up from Scotland, UK 
(the PINE study).  In those who died, the available research and clinical care records were 
reviewed to establish the cause for each patient’s death.  The sensitivity of death 
certificates was calculated to detect any parkinsonian diagnosis mentioned on the death 
certificate, the correct specific diagnosis and the presence of dementia.   The causes of 
death were compared between clinical records and death certificates. 
Results: 277 patients had died (180 men), mean age at diagnosis and death 76.9 years and 
81.9 years respectively. 66.8% of death certificates mentioned any parkinsonian syndrome 
but only 49.5% had the correct diagnosis.  Sensitivity was highest for Parkinson’s disease, 
those who had parkinsonian-related deaths, had longer disease durations and died out of 
hospital.  Death certificates detected 51.2% of those with dementia.  The commonest causes 
of death were pneumonia, end-stage parkinsonism and vascular disease with moderate 
agreement between case-note review and death certification.  
Conclusion: Deaths certificates often do not mention underlying parkinsonism or associated 
dementia and so epidemiological studies should not rely on this as a sole method of 
identifying cases or studying mortality. 
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Parkinsonism is a clinical syndrome characterised by slowness of movement, stiffness 
and tremor [1]. It is caused by a number of neurodegenerative diseases, most commonly 
Parkinson’s disease, but also atypical parkinsonian disorders such as Progressive 
Supranuclear Palsy, Multiple System Atrophy, Corticobasal Degeneration, Dementia with 
Lewy Bodies and vascular parkinsonism. Patients with parkinsonism have increased 
mortality and reduced life expectancy [2, 3]. Dementia is a common complication of many 
of these diseases and contributes to mortality significantly [4].  
 
Death certificates provide routinely available data on the direct causes of death and any 
contributory factors.  This gives an indication of the disease specific mortality (which is 
sometimes used as a proxy for disease incidence over time), but they are also used in 
epidemiology research as a cost-effective way to identify and obtain survival data on 
disease cases in large cohorts, both retrospectively and prospectively.  If accurate, 
information associated with neurodegenerative disorders on death certificates could be 
used to explore disease burden and course, identify causes of death, evaluate the long-
term interventions and recognise priorities for clinical research and health service 
planning [3].  However, the utility of death certificate data for studying the epidemiology 
of parkinsonism may be limited due to inconsistent and inaccurate recording of 
parkinsonism and the causes of death on death certificates [3]. 
 
It is therefore necessary to understand the accuracy of the recording of the 
parkinsonian diagnosis on death certificates and the classification for the cause of death 
in parkinsonian patients. Few studies have looked at this but there is some evidence that 
a parkinsonian diagnoses and any associated dementia data are frequently omitted from 
the death certificates [5-7]. 
 
The main objectives of this study were to use an incident cohort of parkinsonian 
patients to assess: (i) how many patients who died had any or the correct parkinsonian 
syndrome recorded on their death certificate (i.e. the sensitivity of death certificates to 
detect parkinsonian cases if used in cohort studies) ; (ii) factors that may influence the 
sensitivity; (iii) how many patients who died with dementia as part of their parkinsonian 
syndrome had it correctly noted on death certificates. A secondary aim was to assess the 




2.1 Study population 
Data for these analyses came from the PINE study, a prospective observational study 
of an incident cohort of newly diagnosed parkinsonism from 315,000 residents 
registered in general practices in Aberdeen, Scotland within a 4.5-year recruitment 
period starting in 2002.  Detailed methods have been described elsewhere [8].  All 
consenting eligible participants had lifelong annual follow-up with a standardised 
assessment protocol.  The specific parkinsonian diagnosis was confirmed by a single 
consultant neurologist with movement disorder expertise (CC) using expert clinical 
criteria supported by appropriate research criteria for Parkinson’s disease (PD) [9], 
Dementia with Lewy bodies (DLB) [10], progressive supranuclear palsy (PSP) [11], 
multisystem atrophy (MSA) [12], corticobasal degeneration (CBD) [13] and vascular 
parkinsonism [14] and confirmed in some by post-mortem examination.  Dementia 
was diagnosed prospectively by the same consultant neurologist according to clinical 
DSM-IV criteria, supported by annual cognitive assessments (mini-mental state 
examination and mini-mental parkinson’s score) as part of the research protocol and 
by psychiatry input where required on clinical grounds. 
 
Notification of death was performed routinely as part of follow-up and patients also 
gave consent for tagging to the NHS central register in order to obtain their death 
certificates.  Patients had also given consent for their hospital and primary care 
(general practice) notes to be reviewed by the research team.   
 
PINE study participants were excluded from the current analysis if they had not 
given consent for follow-up, were found to have a non-parkinsonian disorder on 
follow-up, were alive on 29 April 2019, were lost to follow-up, or had no available 
death certificate.   
 
2.2 Data extraction 
Demographic and clinical variables were extracted from the PINE database:  sex, age 
at diagnosis and death, final diagnosis of the parkinsonism syndrome, place of death, 
and whether the patient had developed a dementia in association with their 
parkinsonism.  
 
For each patient who had died, one author (HS) reviewed the available research 
records plus hospital records if they died in hospital and primary care records if they 
died at home or in a nursing home to establish the cause of death. The same author 
then classified the cause of death into eight categories:  vascular disease including 
cardiac, cerebrovascular, pulmonary emboli, peripheral vascular or sudden death; 
cancer related; pneumonia; secondary to a fracture or fall; sepsis; renal 
failure/multiple organ failure; end-stage neurodegenerative disease without clear 
other cause; others).  Deaths were then classified as being parkinsonism-related or not, 
namely as a result of a complication of their parkinsonism such as a fracture due to a 
fall, pneumonia due to aspiration or limited mobility or as a result of end stage 
parkinsonism or dementia e.g. if they were bed bound.  Difficult cases were discussed 
with the other author (CC). 
 
All death certificates followed the ICD-10 system with the following information: 
section I(a): disease causing death directly; I(b): other illness, leading to I(a); I(c): other 
illness, leading to I(b); II: other significant conditions contributing to death but not 
leading to the death directly [3].  One author (HS) extracted the following information 
from the free text on each death certificate and confirmed it with the second author:  
whether any parkinsonian diagnosis was recorded either as a cause of death (in section 
I of the death certificate) or as a contributory factor to death (in section II of the death 
certificate); whether it was the correct specific parkinsonian disorder compared to the 
final clinical diagnosis; whether a dementia diagnosis was recorded and if so what 
dementia diagnosis was given.  The cause of death on part I of the death certificate 
also classified using the same eight group classification as used for the patient record.   
 
2.3 Statistical Analysis 
       The sensitivity of death certificates to identify parkinsonian patients, 
subdivided by specific diagnosis, was calculated (i.e. [number identified by death 
certificate]/[total number included in cohort]) for: (1) any parkinsonian diagnosis in 
part I or II of the death certificate; (2) the correct specific parkinsonian diagnosis in 
part I or part II of the death certificate.  Analyses were repeated for patients who 
were defined as having a parkinsonism-related death to assess whether this 
increased sensitivity and whether the sensitivity was affected by place of death 
(hospital vs community), sex, age at death (categorised as <80, 80-85 or over 85) and 
duration of disease from diagnosis to death (categorised as ≤3 years, 3-6 years, > 6 
years). Differences between these groups were compared by Chi-squared statistics. 
In those who had dementia at death, the sensitivity of death certificates to detect 
this was calculated (i.e. [number with dementia mentioned on death 
certificate]/[total number with dementia]) and also the positive predictive value of a 
death certificate record of dementia.   
The proportion of patients with each category of cause of death defined by our case-
note review was calculated and compared with cause of death defined from the 
death certificate using Cohen’s Kappa statistics.     
Analyses were performed using IBM SPSS Statistics version 25 and VassarStats 
statistical computation website for 95% confidence intervals. 
 
2.4 Ethics 
       Patients had given consent for use of their data and ethics approval for the PINE 
study was given by the NHS Grampian Research Ethics Committee and the 




Death certificates were available for 277 out of the 355 parkinsonian patients recruited 
into the PINE follow-up study (Figure 1).  Median duration of follow-up from diagnosis to 
death was 4.2 years (range 0.5-15.1 years).  Seventy-three patients (26%) had the 
diagnosis confirmed at brain post-mortem. Table 1 gives the details of these patients:  it is 
an elderly cohort (mean age at diagnosis 76.9 [SD 8.3]) in keeping with the fact that it was 
a population-based incident cohort and the younger onset patients remain alive.   In 
thirteen of 277 patients there were no hospital or primary care medical records from the 
time of death and so there were no details on the cause of death.  Dementia was 
diagnosed in 172 (62.1%).   
 
3.1 Sensitivity of death certificates for detecting parkinsonian patients (table 2) 
     
When considering all parkinsonian syndromes together, any parkinsonian diagnosis was 
recorded on the death certificates in 66.8% (95% CI 60.9-72.2%). The sensitivity of any 
recorded parkinsonian syndrome was highest for Parkinson’s disease, PSP, MSA and DLB 
(70.3-73.7%) and lowest for vascular parkinsonism (31.4%).   The sensitivity of death 
certificates for recording the correct specific parkinsonian disorder was significantly lower 
at 49.5% (95% CI 43.4-55%) for all causes combined, with Parkinson’s disease again the 
highest at 68.4%.  When the analysis was restricted to only those defined as having died 
as a result of their parkinsonism (parkinsonism-related deaths), the sensitivities for any 
parkinsonian diagnosis (78.2%) or the correct diagnosis (56.4%) on the death certificate 
increased.  
 
3.2 Sensitivity of death certificates by disease duration at death, place of death, sex, and 
age at death (supplementary tables 1 to 4) 
 
There was clear evidence that the sensitivity for recording of any parkinsonism and the 
correct parkinsonian disorder on the death certificate improved with increased duration 
from diagnosis to death:  for any parkinsonism it was 48.5%, 66.2% and 85.7% at three 
years, three to six years and over six years respectively (Chi-squared 31.0, p<0.0001,)  
(supplementary table 1).  This was partly due to the fact there were more parkinsonism-
related deaths as duration of follow-up lengthened:  52.5%, 70.1%, 80.6% at three years, 
three to six years and over six years respectively.  
 
One hundred and thirty-four of 277 patients (48.3%) died in the hospital, 38 cases 
(13.7%) died at home and the remaining 105 (37.9%) died in a nursing home.  It was more 
likely (Chi-squared 21.7, p<0.0001) to find any parkinsonism documented on the death 
certificate for patients who died at home (78.9%) or in a nursing home (77.1%) than in 
hospital (55.2%).  The same applied to a correct diagnosis on the death certificates 
(supplementary table 2).  There was no significant effect of sex or age at death on 
sensitivity (supplementary tables 3 and 4). 
 
   3.3 Accuracy of dementia recorded on the death certificates (table 3) 
     
In those parkinsonian patients with dementia the sensitivity of death certificates to 
detect this was 51.2% (95% CI 44.0-59.4%).  If dementia was documented on the death 
certificate it had a high positive predictive value of 94.6% (95% CI 87.5-98.0%).  For 
Parkinson’s disease alone, the sensitivity and positive predictive values were 54.2% and 
97.8% respectively.  In most patients with dementia, it was recorded as Parkinson’s 
related, Lewy body dementia or unspecified dementia on the death certificate 
(supplementary table 5).  
 
3.4 Causes of death and agreement between medical record review and death certificate 
classification (supplementary table 6) 
     
            The commonest causes of death based on medial record review were pneumonia (30%), 
end stage parkinsonism (24%) and vascular disease (22%), whilst from death certificates 
it was pneumonia (33%), vascular disease (27%) and end stage parkinsonism (15%).  The 
proportion of overall primary causes matching was 62.1%, with a Kappa of 0.52 (p<0.001), 
representing moderate strength of agreement.  As a primary cause of death, vascular 
disease was regarded as achieving the highest match (75.8%), followed by pneumonia 





This study demonstrates the poor sensitivity of using death certificates to identify 
people who die with parkinsonian disorders and to identify those with dementia.   The 
sensitivity was best for well-defined specific diseases such as Parkinson’s disease, PSP, 
MSA and DLB and worse for conditions that are less well characterized such as vascular or 
unspecified parkinsonism.  As expected, the sensitivity was higher if only deaths directly 
related to the parkinsonism were included but even in this group the sensitivity ranged 
from 40% to 86%, when it should have been 100%.  The sensitivity was higher in those 
who had longer disease durations from diagnosis to death and in those who died out of 
hospital.  One explanation for the latter may be that deaths out of hospital were more 
likely to be certified by primary care physicians who have a better knowledge of the 
patients and their underlying medical conditions.  However, the details of who completed 
the certificate were not available to check this.   
 
The findings from this study are in line with prior population-based research although 
most of the previous studies only included people with Parkinson’s disease [3, 6, 7, 15-20]. 
The sensitivity of death certificates for a correct diagnosis of Parkinson’s disease in these 
studies ranged from 60% [20] to 76% [16] compared to 68.4% in the current study.  A study 
from the UK found just 53.6% of those dying with any dementia (not just parkinsonian 
dementia) had it recorded on their death certificates [5], similar to our figure of 51.7%.  
 
Pneumonia was observed as the most common primary cause of death (30%) in the 
current study, comparable to previous studies [18, 19, 20].  However, there was only 
moderate agreement in the cause of death classified from death certificates compared to 
case note review, with under-reporting of end-stage parkinsonism and sepsis as the cause 
of death on death certificates.   
 
There are several strengths in this study including: the representativeness and 
comprehensiveness of the sample which was derived from an incident cohort followed up 
from diagnosis to death with relatively few exclusions (other than lack of consent) and 
very few losses to follow-up or missing death certificates; the inclusion of all types of 
parkinsonism, not just Parkinson’s disease; the likely accuracy of the diagnosis of each 
specific parkinsonian syndrome and dementia through longitudinal application of 
consistent expert clinical diagnosis using all available data;  the classification of the cause 
of death from detailed case-note review.  
 
However, some limitations should also be noted.   The cause of death was established 
from medical records retrospectively.  Ideally, this would have been done prospectively 
but this is difficult to do in a large study.  However, this would only affect results related 
to parkinsonism-related deaths and cause of death and the authors believed in most 
cases the records gave a clear picture of why the patient had died.  In addition, most 
previous studies of the cause of death in parkinsonism have just used death certificate 
data.  The diagnosis of the specific parkinsonian disorder was mainly based on a clinical 
diagnosis rather than post-mortem confirmation (only available in 26%) and so there may 
have been some misclassification of the precise diagnosis.  However, this is unavoidable 
in most parkinsonian research due the limited numbers of post-mortems performed.  
There may also have been some underestimation of the number of people with dementia 
as detailed neuropsychological assessment of all patients was not possible and so some 
people with mild early dementia may have been missed using a clinical definition.  This 
bias would mean the sensitivity of dementia recording on death certificates was over-
optimistic. Finally, there was no control group of non-parkinsonian patients to calculate 
positive predictive values for a parkinsonian diagnosis on the death certificate.  
 
In conclusion, a parkinsonian diagnosis is often not recorded on death certificates in 
people with parkinsonism, even when the death was related to it and the correct diagnosis 
is recorded accurately only 50% of the time. Dementia was also under-recorded.  These 
results indicate that caution should be used in using death certificate data to identify and 
study the epidemiology of parkinsonian disorders and that mortality rates based on them 
are likely to be significant underestimates. Efforts to improve death certification in 
parkinsonian disorders are required. 
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Table 1: Baseline demographic and clinical characteristic of patients with Parkinsonism 
 












Characteristics at baseline 
assessment 
 
Patients with Parkinsonism 
(N=277) 
Mean age baseline (years, [SD*]) 76.9 (8.3) 
Mean age at death (years, [SD*]) 81.9 (8.0) 
Male 180 (65.0%) 
  
Specific Parkinsonian Diagnosis 
 
Total Number  Number with 
dementia 
Idiopathic Parkinson’s Disease 
 
152 (54.9%) 81 (53.3%) 
Dementia with Lewy Bodies 37 (13.4%) 37 (100%) 
Vascular Parkinsonism 35 (12.6%) 24 (68.6%) 
Progressive Supranuclear Palsy 30 (10.8%) 17 (56.7%) 
Multiple System Atrophy 11 (4.0%) 3 (27.3%) 
Dementia with Associated 
Parkinsonism 
7 (2.5%) 7 (100%) 
Parkinsonism (Unspecified) 3 (1.1%) 1 (33.3%) 
Corticobasal Degeneration 2 (0.7%) 2 (100%) 
   
 
Place of Death 
Hospital 134 (48.3%) 
Home 38 (13.7%) 
Nursing Home 105 (37.9%) 
Table 2: Frequency of any and correct parkinsonian diagnosis on death certificates for all 
parkinsonian cases and those with parkinsonian related death 
 
Types of Parkinsonism 
Sensitivity (95% CI* (%)) 
Any parkinsonism on death 
certificate 
Correct parkinsonian diagnosis on 
death certificate 
 All Park related 
death 
All Park related 
death 

























































































Table 3: Presence of Dementia diagnoses on death certificates 
  Clinical Dementia Diagnosis  
 
Dementia on  
Death Certificates  
 YES NO  
YES 88 (51.2%) 5 (4.7%) 93 
NO 84 (48.8%) 100 (95.3%) 184 
  172 107 277 
 
  
Supplementary table 1:  Frequency of any parkinsonism / correct parkinsonian diagnosis on death 









diagnosis on DC 
≤ 3.0 49/101 (48.5%) 29/101 (28.7%) 
3.01-6.0 51/77 (66.2%) 41/77 (53.2%) 
≥6.01 84/98 (85.7%) 74/98 (75.5%) 
 
Supplementary table 2: Frequency of any parkinsonism / correct parkinsonian diagnosis on death 
certificates (DC) in different places of death  
 






diagnosis on DC  
Hospital 74/134 (55.2%) 59/134 (44.0%) 
Home 30/38 (78.9%) 24/38 (63.2% 
Nursing Home 81/105 (77.1%) 61/105 (58.1%) 
 
Supplementary table 3:  Frequency of any parkinsonism / correct parkinsonian diagnosis on death 








diagnosis on DC  
Male  127/180 (70.6%) 96/180 (53.3%) 
Female 58/97 (59.8%) 49/97 (50.5%) 
 
Supplementary table 4:  Frequency of any parkinsonism / correct parkinsonian diagnosis on death 
certificate (DC) by age at death 
 






diagnosis on DC  
≤ 80.0 59/88 (67.0%) 46/88 (52.3%) 
80.01-85.0 58/85 (68.2%) 47/85 (55.3%) 
≥85.0 68/104 (66.8%) 52/104 (50.0%) 
 
  
Supplementary table 5: Number and percentage of cases with various dementia recorded on death 
certificates 
Types of Dementia Cases Number and Percentage 
N (%) 
Parkinson’s disease dementia/ Dementia with 
Lewy Bodies 
33 (37.1) 
Other Dementia 3 (3.3) 
Alzheimer’s Disease 9 (10.1) 
Dementia (Unspecified) 36 (40.5) 
Vascular Dementia 5 (5.7) 
Mixed Dementia 3 (3.3) 
Total 89 (100) 
 
 
Supplementary table 6: Primary causes of death for parkinsonian cases  
 









medical records and 
death certificate 
N (%) 
Pneumonia 83 (30.0) 92 (33.2) 59 (71.1) 
End-stage 
neurodegenerative disease 
67 (24.2) 43 (15.5) 33 (49.3) 
Vascular Disease 62 (22.4) 74 (26.7) 47 (75.8) 
Sepsis 28 (10.1) 14 (5.1) 11 (39.3) 
Cancer 12 (4.3) 10 (3.6) 8 (66.7) 
Renal failure/Multiple 
organ failure 
10 (3.6) 9 (3.2) 5 (50.0) 
Fracture or Fall 1 (0.4) 2 (0.7) 0 (0.0) 
Other Disease/ Unknown 1 (5.0) 33 (11.9) 1 (100.0) 
Total 264 (100.0) 277 (100.0) 164 (62.1) 
*Other disease includes COPD, peritonitis, pleural effusion, gastroenteritis, UTI, Fibrosing alveolitis, 
perforated duodenal ulcer, fragility, acute bowel obstruction, pancreatitis, gastrointestinal bleed, 
choking, Crohn’s disease.  Unknown means missing GPs’ notes. 
 
 
